Design Cloud

Image Name

News

Home page

Party group dynamics

Employee activity

Public Notice of the Environmental Impact Assessment for the R&D Center Incubator Workshop Project of Wanbangde Pharmaceutical Group Co., Ltd.

Date:

01 Mar,2021

The full text is attached. Click to download

Previous page

Wanbangde Pharmaceutical GMP Knowledge Competition Concludes

Wanbangde Pharmaceutical Group Co., Ltd. Announces Public Disclosure of the Environmental Impact Assessment for Its New Technical Renovation Project, which will add annual production capacity for 20 tons of Bifendate API, 980 tons of Norfloxacin API, and 10 tons of Traditional Chinese Medicine Extracts.

Next page

Related Recommendations

Image Name

2023/01/17

Environmental Announcement for Wanbangde Pharmaceutical Group's Annual Production Project of 2,195 Tons of Active Pharmaceutical Ingredients (including 12 products such as 600 tons/year of lipoic acid)

Image Name

2023/01/15

Honors | Wanbangde Pharmaceutical Group Named Among Top 500 High-Tech Enterprises in Zhejiang Province for Innovation Capability!

Image Name

2023/01/15

Good News! Wanbangde Pharmaceutical Group has been named to the "Most Promising Growth Enterprise in China's Pharmaceutical Industry" list for the fourth consecutive year!

< 1...31 32 33...78 > proceed page

Image Name

Website Development: China Enterprise Dynamics Taizhou

Business license

浙ICP备10002622号-38